<?xml version="1.0" encoding="UTF-8"?>
<p>ZIKV is known to be neurotropic; infection halts proliferation of neural progenitor cells and may induce cell death, leading to ZIKV-related microcephaly [
 <xref rid="pntd.0007622.ref020" ref-type="bibr">20</xref>]. Beyond congenital Zika syndrome, direct viral invasion as well as a parainfective or postinfective autoimmune response may contribute to GBS pathogenesis [
 <xref rid="pntd.0007622.ref021" ref-type="bibr">21</xref>, 
 <xref rid="pntd.0007622.ref022" ref-type="bibr">22</xref>]. An association between GBS and ZIKV was first established in a case-control study in French Polynesia [
 <xref rid="pntd.0007622.ref023" ref-type="bibr">23</xref>]. During the 2015â€“2016 ZIKV epidemic, many countries in LAC reported increases in GBS cases, particularly in the beginning of 2016 [
 <xref rid="pntd.0007622.ref024" ref-type="bibr">24</xref>, 
 <xref rid="pntd.0007622.ref025" ref-type="bibr">25</xref>]. In 2016, the World Health Organization (WHO) concluded that ZIKV infection was a plausible trigger for GBS [
 <xref rid="pntd.0007622.ref026" ref-type="bibr">26</xref>]. The chikungunya (CHIKV) [
 <xref rid="pntd.0007622.ref027" ref-type="bibr">27</xref>, 
 <xref rid="pntd.0007622.ref028" ref-type="bibr">28</xref>] and dengue (DENV) viruses [
 <xref rid="pntd.0007622.ref029" ref-type="bibr">29</xref>], two other arboviruses that are endemic in parts of the LAC region, have also been investigated as possible GBS antecedent infectious agents.
</p>
